Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.96 |
| ▸ | PPARG | P37231 | 8/20 | 0.96 |
| ▸ | F7 | P08709 | 7/20 | 0.96 |
| ▸ | F3 | P13726 | 7/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.96 |
| ▸ | PPARD | Q03181 | 6/20 | 0.96 |
| ▸ | PPARA | Q07869 | 6/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7755128 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14695123 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL15994739 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL606015 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL606358 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL371515 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL29226 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL10444557 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL2574641 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14161584 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024141286-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| EP-3806840-A1 | COMPOSITION AND METHODS FOR MODULATION OF ELOVL2 | Youhealth Biotech, Limited (KY) | 2021-04-21 | — | — | EP | claimed |
| WO-2015154192-A1 | USE OF A COMPOSITION COMPRISING A FLAVONOL, A FLAVONOID, AND A FATTY ACID IN THE TREATMENT OF OXIDATIVE INJURIES DUE TO MITOCHONDRIAL DYSFUNCTION | ROBERTSON GEORGE (CA) | 2015-10-15 | — | — | WO | claimed |
| WO-2014035364-A2 | GELATIN ALKYD PEPTIDES AND USES THEREOF | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-03-06 | — | — | WO | claimed |
| EP-1888727-A1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | Pronova BioPharma Norge AS (NO) | 2008-02-20 | — | — | EP | claimed |
| EP-1888728-A1 | FATTY ACID ANALOGUES, I.E. DHA DERIVATIVES FOR USES AS A MEDICAMENT | Pronova BioPharma Norge AS (NO) | 2008-02-20 | — | — | EP | claimed |
| WO-2006117664-A1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | PRONOVA BIOPHARMA NORGE AS (SE) | 2006-11-09 | — | — | WO | claimed |
| WO-2006117668-A1 | FATTY ACID ANALOGUES, I.E. DHA DERIVATIVES FOR USES AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2006-11-09 | — | — | WO | claimed |
| US-20250388720-A1 | ALKYD EMULSION HAVING IMPROVED WATER RESISTANCE AND IMPROVED HARDNESS DEVELOPMENT | ARKEMA FRANCE (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4642830-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA France (FR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4551638-A1 | ALKYD EMULSION HAVING IMPROVED WATER RESISTANCE AND IMPROVED HARDNESS DEVELOPMENT | ARKEMA FRANCE (FR) | 2025-05-14 | — | — | EP | disclosed |
| CN-119731232-A | Alkyd emulsions with improved water resistance and improved hardness development | 阿科玛法国公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2025040408-A1 | ALKYD EMULSION MODIFIED WITH AN UNSATURATED CHAIN BLOCKER | ARKEMA FRANCE (FR) | 2025-02-27 | — | — | WO | disclosed |
| WO-2014035364-A2 | GELATIN ALKYD PEPTIDES AND USES THEREOF | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-03-06 | — | — | WO | disclosed |
| WO-2013071278-A1 | FATTY ACIDS AND METAL IONS COMPOSITIONS AND USES THEREOF | CHOPRA MANINDER (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130046020-A1 | EICOSAPENTAENOIC ACID CONCENTRATE | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-02-21 | — | — | US | disclosed |
| EP-2102139-A2 | OMEGA-3 LIPID COMPOUNDS | Pronova Biopharma Norge AS (NO) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008142482-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-27 | — | — | WO | disclosed |
| US-5698594-A | ADMINISTERING MIXTURE OF ALL-Z OMEGA-3 FATTY ACIDS INCLUDING 5,8,11,14,17-EICOSAPENTAENOIC ACID, 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, 6,9,12,15,18-HENEICOSAPENTAENOIC ACID | NORSK HYDRO A.S (NO) | 1997-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388720-A1 | ALKYD EMULSION HAVING IMPROVED WATER RESISTANCE AND IMPROVED HARDNESS DEVELOPMENT | DRD1, DRD2, DRD3 | ALDH1A1 200/4885PPARG 1669/4885F7 2051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.